aTyr Pharma Inc

Healthcare · EUR · F

471A

Price

€0.36

+12.70%

Cap

€34.91M

Earnings

0/4 beat

30d Trend

-43.3%

471A

Loading chart data...

0 days · % change from startPowered by Brain47

52-week range2%

€0.25€5.42

Near 52-week lows — potential value or falling knife

Earnings history

Q3 2025

MISS

-0.26 vs -0.19

Q2 2025

MISS

-0.22 vs -0.18

Q1 2025

MISS

-0.17 vs 0

Q2 2021

MISS

-0.64 vs -0.51

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candida…

BRAIN47 SIGNAL

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Running historical backtest...

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.